Advanced Rehabilitation Technology for Neurological Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether advanced robotic devices and technology in inpatient rehab for people with neurological conditions can improve recovery outcomes and be cost-effective. Participants will receive either traditional rehab or rehab with new tech tools, such as EKSO Bionics (a robotic exoskeleton) and Thera-Trainer, to determine if the technology enhances recovery speed or quality. The trial seeks participants currently in rehab with a neurological diagnosis who can sit or stand upright for rehab activities. The goal is to assess whether the technology can deliver similar or better results at a lower cost. As an unphased trial, this study offers participants the chance to contribute to innovative research that could transform future rehabilitation practices.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators or your doctor for guidance.
What prior data suggests that these robotic devices and advanced technologies are safe for neurological rehabilitation?
Research shows that EKSO Bionics exoskeletons, such as the EKSO-GT, are generally safe for people with spinal cord injuries. These devices help patients walk safely in everyday settings. Studies have found that patients tolerate them well during rehab sessions, with regular safety checks conducted.
For Fourier Intelligence's devices, detailed safety information is not readily available. However, their robotic rehab systems have aided recovery from mobility issues and brain conditions.
Thera-Trainer's technology, particularly in robot-assisted walking rehab, has shown promising results in improving walking abilities. Although specific safety data is not highlighted, the technology benefits outcomes in neurological conditions.
Tyromotion's devices, like the Amadeo, have been used in studies that show improvements in limb function after a stroke. Evaluations of their safety and acceptance in high-intensity training have been positive, indicating they are well-received by patients.
In summary, while detailed safety data is limited for some technologies, research suggests these advanced rehab devices are generally safe and effective for aiding recovery in neurological patients.12345Why are researchers excited about this trial?
Researchers are excited about the advanced rehabilitation technology being explored for neurological disorders because it integrates cutting-edge robotics and AI to enhance recovery. Unlike traditional physical therapy, which relies heavily on manual techniques by therapists, these technologies—like EKSO Bionics and Fourier Intelligence—offer precise, customizable support and feedback to patients. This can lead to more efficient and targeted rehabilitation, potentially speeding up recovery times and improving outcomes for patients with conditions like stroke or spinal cord injuries. Additionally, these technologies can provide consistent and repeatable therapy sessions, which are crucial for neurological rehabilitation.
What evidence suggests that this trial's treatments could be effective for neurological disorders?
This trial will compare inpatient rehabilitation with advanced rehabilitation technology (ART) to rehabilitation without ART. Research has shown that using EKSO Bionics exoskeletons, one of the technologies in this trial, can help stroke patients walk better and improve their overall physical abilities. In a study of 310 stroke patients, participants demonstrated clear improvements in these areas. Fourier Intelligence's robotic solutions, also part of this trial, are designed to aid recovery from movement problems and brain-related conditions. Thera-Trainer’s therapy devices, another technology being tested, have significantly improved walking in patients with serious neurological issues. Tyromotion's robotic devices, included in this trial, have enhanced arm function and reduced overall disability. These technologies hold promise for improving rehabilitation outcomes for people with neurological disorders.12467
Who Is on the Research Team?
Brett Schoen, MD
Principal Investigator
Rehabilitation Hospital of Overland Park
Are You a Good Fit for This Trial?
This trial is for adults over 18 with neurological disorders who are in inpatient rehab and can stay at least 7 days. They must be able to communicate, follow commands, fit into a device, and tolerate certain positions. Excluded are those with conditions limiting study benefits or involved in another study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive inpatient rehabilitation with or without advanced rehabilitation technology
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- EKSO Bionics
- Fourier Intelligence
- Thera-Trainer
- Tyromotion
Trial Overview
The study tests if using robotic devices like Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics during rehab gives similar or better results than standard therapy alone. It's randomized: some get technology-assisted therapy; others don't.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Inpatient rehabilitation with advanced rehabilitation technology
Inpatient rehabilitation without advanced rehabilitation technology
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rehabilitation Hospital of Overland Park
Lead Sponsor
Discovery Statistics
Collaborator
Published Research Related to This Trial
Citations
Physiotherapists' Experiences Using the Ekso Bionic ...
An exploratory qualitative study of three physiotherapists working at a neurological rehabilitation centre in Eastern Canada was conducted using ...
Outcomes of Using EksoNR in Inpatient Rehab
Average Stroke Patient Statistics. The following data represents the “average” scoring of all of their 310 stroke patients. It is provided so that anyone may ...
How Effective Is Exoskeleton Rehabilitation?
In this article, we will explore the current state of research on exoskeleton rehabilitation in physical therapy and consider the potential benefits.
Exoskeleton-Assisted Rehabilitation and Neuroplasticity in ...
Exoskeleton serves as an emerging and promising tool for rehabilitation, especially in promoting neuroplasticity and alleviating SCI-related complications.
Enhanced Rehabilitation Outcomes of Robotic-Assisted ...
This study supports previous findings, demonstrating that RAGT using the EksoNR lower extremity exoskeleton improves gait and functional status in stroke ...
Locomotor Training With Exoskeleton EKSO-GT in Patients ...
Data on the safety and tolerability of the EKSO-GT training are recorded at the beginning and at the end of each session, however a synthesis of safety ...
Clinical effectiveness and safety of powered exoskeleton ...
Powered exoskeletons allow patients with SCI to safely ambulate in real-world settings at a physical activity intensity conducive to prolonged use and known to ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.